Epitalon Research

Khavinson VK, Bondarev IE, Butyugov AA

The foundational study establishing Epitalon’s telomerase-activating properties. Using human fetal lung fibroblast cell cultures and the TRAP (Telomeric Repeat Amplification Protocol) assay, the researchers demonstrated that Epitalon activated expression of the hTERT telomerase catalytic subunit, significantly increased telomerase enzyme activity, and extended the proliferative lifespan of cells beyond the Hayflick limit — from termination at the 34th passage to continued division past the 44th passage, an extension of more than 10 additional cell doublings. This was the first study establishing that a simple tetrapeptide could reactivate telomerase in normal human somatic cells, a finding with profound theoretical implications for aging biology.

Al-Dulaimi S, Thomas R, Matta S, Roberts T

The most significant independent replication of Epitalon’s telomere effects — published in 2025 by a UK-based research group unaffiliated with the Khavinson lab. Using breast cancer cell lines and normal epithelial and fibroblast cells, the study confirmed dose-dependent telomere length extension in normal cells through hTERT upregulation and telomerase activation. It also found that cancer cells extended telomeres through an alternative pathway (ALT — Alternative Lengthening of Telomeres), with only minor ALT activity in normal cells. This independent confirmation significantly strengthens the telomerase-activation evidence base for Epitalon, as it moves the key finding beyond a single research group.

Kossoy G, et al.

A comprehensive 2025 review synthesizing the full body of Epitalon research across telomere biology, antioxidant activity, lifespan extension, cancer research, and circadian regulation. Key findings documented: Epitalon increased lifespan of Drosophila by up to 16%; increased antioxidant enzyme activities (SOD, glutathione peroxidase) in aging rats; reduced spontaneous tumor incidence and metastases in mice; increased telomere lengths in blood cells of elderly humans aged 60–65 and 75–80; and restored melatonin secretion in aged monkeys and humans. The review also covers Epitalon’s DNA-binding mechanism — specifically its interaction with ATTTC sequences in the promoter region of the telomerase gene — providing a molecular explanation for its telomerase-activating effect.

de Wit H, PhD — Healthspan Research Review

A balanced independent evidence review from a PhD-led research team not affiliated with the Khavinson group. The review identifies Epitalon as a multi-pathway geroprotector that acts on five hallmarks of aging simultaneously: telomere maintenance, epigenetic regulation, oxidative stress resilience, immune recalibration, and circadian rhythm restoration — making it one of the broadest-reaching peptides studied in longevity science. The review is appropriately candid about limitations: most evidence comes from a single research group, large-scale independent clinical trials are absent, and the extraordinary claims (especially lifespan extension) require independent validation before strong conclusions can be drawn. An essential balanced read alongside the primary Khavinson literature.